Yan Ning
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
- Chemokine receptors and signaling
- Cancer Immunotherapy and Biomarkers
- Cytokine Signaling Pathways and Interactions
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
- Oncology 76
- Colorectal Cancer Treatments and Studies 51
- Cancer Treatment and Pharmacology 13
- Cancer Immunotherapy and Biomarkers 11
- Cytokine Signaling Pathways and Interactions 8
-
- Genetic factors in colorectal cancer 20
- Co-authors
- Dongyun Yang (64 shared papers)Heinz‐Josef Lenz (52 shared papers)Wu Zhang (36 shared papers)Melissa J. LaBonte (16 shared papers)Georg Lurje (14 shared papers)Robert D. Ladner (6 shared papers)Thomas Winder (8 shared papers)Alexandra Pohl (8 shared papers)
- Journals
- Journal of Clinical Oncology (28 papers)The Pharmacogenomics Journal (12 papers)Annals of Oncology (6 papers)Clinical Cancer Research (5 papers)Molecular Cancer Therapeutics (4 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Yan Ning
100 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 118
- Oncology 1.3k
- Cancer Research 548
- Immunology 441
- Pathology and Forensic Medicine 273
- Hepatology 116
Countries citing papers authored by Yan Ning
This map shows the geographic impact of Yan Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ning more than expected).
Fields of papers citing papers by Yan Ning
This network shows the impact of papers produced by Yan Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ning. The network helps show where Yan Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 355 | |
| 2 | 2012 | 238 | |
| 3 | 2011 | 164 | |
| 4 | 2012 | 118 | |
| 5 | 2010 | 107 | |
| 6 | 2012 | 102 | |
| 7 | 2013 | 99 | |
| 8 | 2011 | 87 | |
| 9 | 2017 | 85 | |
| 10 | 2011 | 72 | |
| 11 | 2012 | 68 | |
| 12 | 2009 | 48 | |
| 13 | 2016 | 44 | |
| 14 | 2010 | 43 | |
| 15 | 2015 | 41 | |
| 16 | 2008 | 40 | |
| 17 | 2012 | 39 | |
| 18 | 2009 | 38 | |
| 19 | Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study). | 2010 | 31 |
| 20 | 2017 | 29 |
About Yan Ning
Yan Ning is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research, having authored 105 papers that have together received 2.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (51 papers), Genetic factors in colorectal cancer (20 papers), Cancer Treatment and Pharmacology (13 papers), Lung Cancer Treatments and Mutations (13 papers), Cancer Immunotherapy and Biomarkers (11 papers), Cancer Genomics and Diagnostics (11 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (548 citations), Immunology (441 citations), Pathology and Forensic Medicine (273 citations) and Hepatology (116 citations). Yan Ning has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Dongyun Yang, Heinz‐Josef Lenz, Wu Zhang, Melissa J. LaBonte, Georg Lurje, Robert D. Ladner, Thomas Winder, Alexandra Pohl, Pierre Bohanes and Philipp Manegold. Their work appears in journals such as Journal of Clinical Oncology, The Pharmacogenomics Journal, Annals of Oncology, Clinical Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.